Two recent studies suggest that 3KSR plays a critical role in cancer cell fate by eliminating cytotoxic 3KS when SPT activity is elevated, e.g., in breast cancer (84), and maintaining ER homeostasis and the response to unfolded proteins in leukemia (85). This evidence concerns the gene AGXT and breast cancer.